During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

SIMPLE SUMMARY: Hepatitis C virus (HCV) therapy lowers risk of liver cancer. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) regulate immune response and pathogenesis of disease. We evaluated soluble markers of interferon signaling and liver cirrhosis, plasma miRNAs and other non-coding RNAs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Damjanovska, Sofi, Alao, Hawwa, Zebrowski, Elizabeth, Kowal, Corinne, Kostadinova, Lenche, Davitkov, Perica, Falck-Ytter, Yngve, Shive, Carey L., Cartwright, Michael, Richardson, Brian, Wald, David, Cameron, Mark, Valadkhan, Saba, Anthony, Donald D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495750/
https://www.ncbi.nlm.nih.gov/pubmed/36138741
http://dx.doi.org/10.3390/biology11091262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495750/
https://www.ncbi.nlm.nih.gov/pubmed/36138741
http://dx.doi.org/10.3390/biology11091262

Ejemplares similares